Last reviewed · How we verify

NCT02369055

Quality of Life and Rehabilitation Pathway in Northern Norway and Denmark.

Completed Last updated 4 December 2019
What this trial tests

trial in Stroke in 369 participants. Completed in 25 October 2019.

Timeline
15 March 2014
Primary endpoint
31 January 2017
25 October 2019

Quick facts

Lead sponsorUniversity Hospital of North Norway
StatusCompleted
Study typeOBSERVATIONAL
Enrollment369
Start date15 March 2014
Primary completion31 January 2017
Estimated completion25 October 2019
Sites1 location across Norway

Conditions studied

Sponsor

University Hospital of North Norway

Who can join

18 and older, any sex, with Stroke or Quality of Life. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to analyze and describe rehabilitation pathways of stroke patients in a region of North Norway and Central Denmark Region in relation to how patients perceive quality of life, health and functioning one year post stroke. The study will consist of 1) Translate, cross-cultural adapt and validate a stroke-specific health-related questionnaire 2) Describe the level of quality of life and rehabilitation pathway in the two countries 3) In-depth interviews of a smaller group of patients for a more complex understanding The study is part of a larger prospective observational multicenter-study of two patient cohorts with stroke.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. E-Poster Viewing
    · 2019 · cited 2×

Verify or expand the search:

Other recruiting trials for Stroke

Currently open trials in the same condition.

Other University Hospital of North Norway trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02369055.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing